[HTML][HTML] Concurrent neoadjuvant chemoradiotherapy for Siewert II and III adenocarcinoma at gastroesophageal junction
J Wang, J Zhang, X Qiao, Q Zhao, Y Li, B Tan… - The American journal of …, 2015 - Elsevier
Objective This study was conducted to investigate the efficacy and safety of using a
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …
Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction.
Q Zhao, Y Li, J Wang, J Zhang, X Qiao… - The American Journal …, 2015 - europepmc.org
Objective This study was conducted to investigate the efficacy and safety of using a
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …
[HTML][HTML] Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction
J Wang, J Zhang, X Qiao, Q Zhao, Y Li… - The American Journal …, 2015 - amjmedsci.com
Objective This study was conducted to investigate the efficacy and safety of using a
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …
[HTML][HTML] Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction
Q Zhao, Y Li, J Wang, J Zhang, X Qiao… - The American Journal …, 2015 - ncbi.nlm.nih.gov
Objective: This study was conducted to investigate the efficacy and safety of using a
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …
Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction
Q Zhao, Y Li, J Wang, J Zhang, X Qiao, B Tan, Y Tian… - 2015 - pubmed.ncbi.nlm.nih.gov
Objective This study was conducted to investigate the efficacy and safety of using a
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …
Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction.
Q Zhao, Y Li, J Wang, J Zhang, X Qiao… - The American Journal …, 2015 - europepmc.org
Objective This study was conducted to investigate the efficacy and safety of using a
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …